-
1
-
-
10744225301
-
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial
-
Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
-
(2004)
JAMA
, vol.291
, pp. 1071-1080
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Schoenhagen, P.3
Brown, B.G.4
Ganz, P.5
Vogel, R.A.6
Crowe, T.7
Howard, G.8
Cooper, C.J.9
Brodie, B.10
-
2
-
-
33645524176
-
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
-
ASTEROID Investigators
-
Nissen S.E., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., Davignon J., Erbel R., Fruchart J.C., et al., ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
-
(2006)
JAMA
, vol.295
, pp. 1556-1565
-
-
Nissen, S.E.1
Nicholls, S.J.2
Sipahi, I.3
Libby, P.4
Raichlen, J.S.5
Ballantyne, C.M.6
Davignon, J.7
Erbel, R.8
Fruchart, J.C.9
-
3
-
-
33846863146
-
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
-
Nicholls S.J., Tuzcu E.M., Grasso A.W., Schoenhagen P., Hu T., Wolski K., Crowe T., Desai M.Y., Hazen S.L., Kapadia S.R., and Nissen S.E. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297 (2007) 499-508
-
(2007)
JAMA
, vol.297
, pp. 499-508
-
-
Nicholls, S.J.1
Tuzcu, E.M.2
Grasso, A.W.3
Schoenhagen, P.4
Hu, T.5
Wolski, K.6
Crowe, T.7
Desai, M.Y.8
Hazen, S.L.9
Kapadia, S.R.10
Nissen, S.E.11
-
4
-
-
33845989108
-
Atherosclerosis regression, vascular remodeling, and plaque stabilization
-
Klein L.W. Atherosclerosis regression, vascular remodeling, and plaque stabilization. J Am Coll Cardiol 49 (2007) 271-273
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 271-273
-
-
Klein, L.W.1
-
5
-
-
0242577955
-
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial
-
Nissen S.E., Tsunoda T., Tuzcu E.M., Schoenhagen P., Cooper C.J., Yasin M., Eaton G.M., Lauer M.A., Sheldon W.S., Grines C.L., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
-
(2003)
JAMA
, vol.290
, pp. 2292-2300
-
-
Nissen, S.E.1
Tsunoda, T.2
Tuzcu, E.M.3
Schoenhagen, P.4
Cooper, C.J.5
Yasin, M.6
Eaton, G.M.7
Lauer, M.A.8
Sheldon, W.S.9
Grines, C.L.10
-
6
-
-
0037454046
-
Mechanisms of plaque vulnerability and rupture
-
Shah P.K. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 41 suppl (2003) 15S-22S
-
(2003)
J Am Coll Cardiol
, vol.41
, Issue.SUPPL
-
-
Shah, P.K.1
-
7
-
-
0035897696
-
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
8
-
-
33645103550
-
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
-
Cohen J.C., Boerwinkle E., Mosley T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 (2006) 1264-1272
-
(2006)
N Engl J Med
, vol.354
, pp. 1264-1272
-
-
Cohen, J.C.1
Boerwinkle, E.2
Mosley, T.H.3
Hobbs, H.H.4
-
9
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial
-
CAMELOT Investigators
-
Nissen S.E., Tuzcu E.M., Libby P., Thompson P.D., Ghali M., Garza D., Berman L., Shi H., Buebendorf E., Topol E.J., and CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial. JAMA 292 (2004) 2217-2225
-
(2004)
JAMA
, vol.292
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
Thompson, P.D.4
Ghali, M.5
Garza, D.6
Berman, L.7
Shi, H.8
Buebendorf, E.9
Topol, E.J.10
|